Mai Capital Management Biotechnology

Mai Capital Management

$13.2 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SRPT Sarepta Therapeutics, Inc.	$9.02B	$7,000 0.0% of portfolio	59	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$427M	$6,000 0.0% of portfolio	381	Q4 2024 New
SAVA Cassava Sciences Inc	$104M	$6,000 0.0% of portfolio	2,592	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$159M	$5,000 0.0% of portfolio	400	Q4 2024 New
RPRX Royalty Pharma PLC	$14.6B	$5,000 0.0% of portfolio	208	Q4 2024 New
VCYT Veracyte, Inc.	$2.42B	$4,000 0.0% of portfolio	125	Q4 2024 New
GERN Geron Corp	$657M	$3,000 0.0% of portfolio	1,000	Q4 2024 New
HUMA Humacyte, Inc.	$347M	$3,000 0.0% of portfolio	653	Q4 2024 New
ARGX Argenx Se	$34.6B	$2,000 0.0% of portfolio	4	Q4 2024 New
GMAB Genmab A/S	$15B	$2,000 0.0% of portfolio	138	Q4 2024 New
PASG Passage Bio, Inc.	$27.8M	$2,000 0.0% of portfolio	4,000	Q4 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$2.94B	$2,000 0.0% of portfolio	53	Q4 2024 New
FENC Fennec Pharmaceuticals Inc.	$179M	$1,000 0.0% of portfolio	200	Q4 2024 New
GALT Galectin Therapeutics Inc	$90.9M	$1,000 0.0% of portfolio	1,000	Q4 2024 New
NTLA Intellia Therapeutics, Inc.	$825M	$1,000 0.0% of portfolio	128	Q4 2024 New
LYEL Lyell Immunopharma, Inc.	$176M	$1,000 0.0% of portfolio	2,000	Q4 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.74B	$1,000 0.0% of portfolio	4	Q4 2024 New
MAIA Maia Biotechnology, Inc.	$21.5M	$1,000 0.0% of portfolio	675	Q4 2024 New
MREO Mereo Biopharma Group PLC	$306M	$1,000 0.0% of portfolio	309	Q4 2024 New
SWTX Spring Works Therapeutics, Inc.	$3.33B	$1,000 0.0% of portfolio	51	Q4 2024 New
TERN Terns Pharmaceuticals, Inc.	$141M	$1,000 0.0% of portfolio	189	Q4 2024 New
TSVT 2seventy Bio, Inc.	$94.7M	$0 0.0% of portfolio	100	Q4 2024 New
ABSI Absci Corp	$375M	$0 0.0% of portfolio	338	Q4 2024 New
AGIO Agios Pharmaceuticals, Inc.	$1.88B	$0 0.0% of portfolio	20	Q4 2024 New
AIM Aim Immuno Tech Inc.	$6.25M	$0 0.0% of portfolio	27	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$280M	$0 0.0% of portfolio	1	Q4 2024 New
AMRN Amarin Corp Plcuk	$222M	$0 0.0% of portfolio	1,200	Q4 2024 New
ARMP Armata Pharmaceuticals, Inc.	$75.2M	$0 0.0% of portfolio	71	Q4 2024 New
ATAI Atai Life Sciences N.V.	$274M	$0 0.0% of portfolio	300	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$255M	$0 0.0% of portfolio	95	Q4 2024 New
LIFE A Tyr Pharma Inc	$53.2M	$0 0.0% of portfolio	215	Q4 2024 New
CDMO Avid Bioservices, Inc.	$776M	$0 0.0% of portfolio	20	Q4 2024 New
CDXS Codexis, Inc.	$257M	$0 0.0% of portfolio	138	Q4 2024 New
CGTX Cognition Therapeutics Inc	$11.1M	$0 0.0% of portfolio	200	Q4 2024 New
CUE Cue Biopharma, Inc.	$41.8M	$0 0.0% of portfolio	350	Q4 2024 New
EDIT Editas Medicine, Inc.	$126M	$0 0.0% of portfolio	22	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.14B	$0 0.0% of portfolio	348	Q4 2024 New
MGNX Macrogenics Inc	$148M	$0 0.0% of portfolio	140	Q4 2024 New
NKTX Nkarta, Inc.	$85.1M	$0 0.0% of portfolio	100	Q4 2024 New
ONCY Oncolytics Biotech Inc	$41.1M	$0 0.0% of portfolio	526	Q4 2024 New
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	999	Q4 2024 New
RGNX Regenxbio Inc.	$285M	$0 0.0% of portfolio	95	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	300	Q4 2024 New
SGMO Sangamo Therapeutics, Inc	$150M	$0 0.0% of portfolio	100	Q4 2024 New
SVRA Savara Inc	$281M	$0 0.0% of portfolio	2	Q4 2024 New
VXRT Vaxart, Inc.	$62M	$0 0.0% of portfolio	1,000	Q4 2024 New
PCVX Vaxcyte, Inc.	$4.4B	$0 0.0% of portfolio	2	Q4 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	21	Q4 2024 New
VIRX Viracta Therapeutics, Inc.	$1.13M	$0 0.0% of portfolio	4,018	Q4 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	12	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.